EyePoint, Inc.

US$0.36As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:EYPTHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (33.29%)
Div yield —
ROE (148.70%)
Biotechnology
Beta (5Y) 1.91
PE TTM —
TSR TTM (97.25%)
Mkt cap US$31.04M
ROIC (86.42%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.352
(2.27%)
25.58%
Hold 12|2|12|8|0
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.01
0.01
0.01
0.01
1.33%
16.36%
19.27%
24.84%
Revenue$M
3.488
3.572
3.749
3.788
6.59%
9.14%
13.58%
9.91%
Peers (US$31.04M)
Cap (US$)
PE
32.83M
—
Capital
TTM
5Y
10Y
Leveragex
0.290
(0.057)
(0.055)
EBIT/Intx
1.261
0.225
0.214
Own earn%
(6.14)
(60.89)
(63.78)
Sh yield%
30.78
34.19
31.94
Owners
Insiders/Inst%
5.53
28.88
Short interest%
1.60
SBC / revenue%
2.20
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
15
Op margin range%
24–31
$1 testx
0.0
Incr. ROIC%
45